
Responders at week 104 demonstrated more significant changes from baseline and achieved normative values in PROs compared with non-responders.
Responders at week 104 demonstrated more significant changes from baseline and achieved normative values in PROs compared with non-responders.
Factors independently associated with persistently active RA included age, gender, previous or current smoking status, and social deprivation.
At 12 weeks, significantly more patients with fibromyalgia receiving the smartphone-based intervention reported clinical improvements compared with the control group.
Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Of the 333 patients with psoriatic arthritis (PsA) and 457 patients with axial spondyloarthritis (axSpA), there were 1.09 serious infections per 100 patient-years.
At week 52, sustained remission was observed in significantly more patients receiving sarilumab compared with placebo.
Guidelines aim to help the identification of ILD in patients with rheumatic disease and aid in improving the management of patients.
Patients with IBD-RA and depression were younger, more likely to be female, and were more frequently White compared with controls.
Patients with SLE who reported being more satisfied in their lives were more likely to have higher physical and mental component summary scores.
Regardless of a prior history of swallowed topical corticosteroids, dupilumab was proven to be an effective treatment in patients with eosinophilic esophagitis.
Polypharmacy was significantly higher in patients with psoriatic arthritis when compared with controls, according to a new study.
Published: June 2nd 2023 | Updated:
Published: August 9th 2024 | Updated:
Published: July 20th 2024 | Updated:
Published: September 8th 2023 | Updated:
Published: October 13th 2023 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.